Physician

Anita N Demas, M.D.

According to 2025 Medicare claims, Anita Demas, M.D. (NPI: 1174646012) practices internal medicine in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is PACIFIC HEIGHTS MEDICAL GROUP (NPI: 1376693200; TIN: 942583839) and primary practice location at 94115-1932.

Demas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 11,639 HCPCS/CPT codes, and received $630,401 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,897 prescription claims across 291 beneficiaries totaling $185,253 in drug costs, led by Arexvy (Rsvpref3 Antigen/As01e/Pf). DME data shows 11 claims. Open Payments data shows 3 records totaling $62. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $136,961 to $630,401. Similarly, Part D prescription costs have risen steadily, from $101,945 to $185,253. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $667 to $1,406.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	232	2,592	$136,961
2016	222	2,541	$142,171
2017	264	2,489	$136,872
2018	319	3,356	$193,166
2019	292	3,062	$167,187
2020	386	4,694	$241,024
2021	359	4,506	$273,193
2022	334	5,166	$330,094
2023	332	8,557	$476,599
2024	337	11,639	$630,401

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	210	1,534	$101,945
2016	200	1,497	$109,458
2017	219	1,444	$101,417
2018	241	1,577	$108,708
2019	256	1,936	$141,332
2020	346	2,398	$185,062
2021	340	2,208	$170,053
2022	285	1,822	$133,816
2023	313	2,115	$169,131
2024	291	1,897	$185,253

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$286
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$1,529

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	816	$114
99497	Advance care planning, first 30 minutes	249	257	$96
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	248	248	$31
G0442	Annual alcohol misuse screening, 5 to 15 minutes	247	247	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	249	974	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Arexvy	Rsvpref3 Antigen/As01e/Pf	95	965	$29,177
Ozempic	Semaglutide	13	756	$23,967
Eliquis	Apixaban	15	1,035	$18,682
Invokana	Canagliflozin	12	360	$6,848
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	345	$5,097

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4390	Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each	N	N/R	11	$1,529

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$62	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anita N. Demas, M.D.?

Tedicare shows public-source Medicare data for Anita N. Demas, M.D. (NPI 1174646012), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita N. Demas, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anita N. Demas, M.D.?

Anita N. Demas, M.D. is linked to PACIFIC HEIGHTS MEDICAL GROUP (billing NPI 1376693200) in the available physician profile data.

Does Anita N. Demas, M.D. have Open Payments data?

Anita N. Demas, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.